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Available online 9 January 2016Background: Phenylketonuria (PKU) is characterized by phenylalanine (Phe) accumulation to toxic levels due to
the low activity of phenylalanine-hydroxylase. PKU patients must follow a Phe-restricted diet, which may put
them in risk of nutritional disturbances. Therefore, we aimed to characterize body composition parameters
and nutritional status in Brazilian PKU patients also considering their metabolic control.
Methods: Twenty-seven treated PKU patients older than 5 years, and 27 age- and gender-matched controls, were
analyzed for anthropometric features and body composition by bioelectrical impedance (BIA). Patients'metabol-
ic control was assessed by historical Phe levels.
Results: There was no effect of PKU type, time of diagnosis, or metabolic control for any analyzed parameter.
About 75% of patients and controls were eutrophic, according to their BMI values. There were no difference
between groups regarding body composition and other BIA-derived parameters.
Conclusions: Brazilian PKU patients do not show differences in body composition and nutritional status in
comparison with controls, regardless metabolic control. Although similar to controls, PKU patients may be in
risk of disturbed nutritional and metabolic markers as seen for the general population.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:





Phenylketonuria (PKU, OMIM: 261600) is an inherited metabolic
disorder characterized by deﬁcient (mild PKU) to null (classical PKU)
activity of the hepatic enzyme phenylalanine (Phe) hydroxylase (PAH,
EC 1.14.16.1), which converts Phe into tyrosine. PKU patients show
high levels of Phe in the plasma and, consequently, in the brain [1].
Phe in high levels is toxic to the brain; therefore, untreated PKUpatients
show severe mental retardation. In order to avoid brain damage, pa-
tients must be early diagnosed and follow a lifelong Phe-restricted
diet. This diet consists of low-Phe foods along with supplementationzola), tatinalin@gmail.com
n.rijn@umcg.nl (M. van Rijn),
.S. Perry),
pa.edu.br (I.V.D. Schwartz).
. This is an open access article underof an especial L-amino acid mixture [2]. Besides effective in lowering
Phe levels, the Phe-restricted diet is hard to accomplish, so that patients
may show high Phe levels in plasma reﬂecting poor dietary control
[3–6].
Both high Phe levels and the dietary treatment may lead to nutri-
tional deﬁciencies. First, increased levels of Phe have been related to dis-
turbed synthesis of hormones and cytokines, such as catecholamines
and adiponectin, thus affecting body metabolism [7,8]. Moreover, the
diet restricts several sources of natural protein, thereby impairing the
intake of essential micro- and macronutrients [9]. Finally, the L-amino
acid mixture is composed by synthetic nutrients, which may compro-
mise biological availability [4]. Because of those above-mentioned rea-
sons, concern has been emerged on nutritional status [2], linear
growth [10], body composition [11], and risk of overweight and obesity
in PKU children [12,13]. Despite that, some studies did not ﬁnd differ-
ences in the growth and body composition parameters in PKU patients
comparedwith controls [14,15]. Therefore, perhaps the risk of disturbedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1









#1 6 Male Late Mild Poor
#2 7 Female Late Classical Poor
#3 11 Female Late Mild Poor
#4 11 Female Early Mild Good
#5 11 Male Early Classical Poor
#6 11 Female Late Mild Poor
#7 11 Male Early Mild Poor
#8 11 Female Early Mild Poor
#9 11 Female Late Classical Poor
#10 12 Male Early Classical Poor
#11 12 Male Early Mild Good
#12 12 Female Late Mild Poor
#13 12 Male Late Mild Poor
#14 13 Female Early Classical Poor
#15 13 Female Late Mild Good
#16 14 Male Late Classical Good
#17 14 Female Early Classical Good
#18 14 Female Late Mild Good
#19 15 Male Late Classical Good
#20 16 Female Late Classical Good
#21 16 Male Late Mild Good
#22 16 Male Early Classical Good
#23 17 Male Early Classical Poor
#24 19 Female Late Mild Good
#25 22 Male Early Classical Good
#26 22 Male Late Mild Good
#27 25 Male Late Classical Poor
a See the text for details on classiﬁcation.
17P.N. Mazzola et al. / Molecular Genetics and Metabolism Reports 6 (2016) 16–20body composition in PKU just reﬂects the increased rates of nutritional
imbalance as well as overweight and obesity seen in the general popu-
lation and that varies from country to country. In addition, treatment
management of PKU in Brazil needs special attention. In Brazil, themet-
abolic formula is supplied free of charge by the government, but
the commercial low-Phe products are neither easily available nor typi-
cally reimbursed by insurance policies [5]. Besides that, the Neonatal
Screening for PKU has been organized as a National Public Policy only
since 2001, still existing many patients in the country diagnosed at a
late age.
Bioelectrical impedance (BIA) represents a useful evaluation of
overall body composition and nutritional status in PKUpatients, in addi-
tion to the commonly analyzed bodymass index (BMI). In this way, the
BIA-derived data such as body fat mass (FM) and fat-free mass (FFM)
proportion showmore accurate values on real tissue mass than BMI es-
timations [16]. BIA analysis also provides an overview on metabolism
and overall cellular integrity by the ratio between extracellular mass
and body cell mass (ECM/BCM) and the phase angle (PA), respectively.
These BIA-derived values are described as prognostic markers during
hospitalization [17] and conditions like post-operative complications
[18], kidney dysfunction [19], classical homocystinuria [20], and cancer
[21]. In this way, abnormal values of ECM/BCM ratio and/or PA have
been related to increased inﬂammatory processes [22]. Nutritional dis-
turbances such as unbalanced polyunsaturated fatty acid intake [23]
and obesity [24] have been related to increased inﬂammation. Because
the PKU treatment seems to compromise the nutritional status in PKU
patients, evaluating ECM/BCM ratio and PA can be of value to evaluate
nutritional condition in PKU.
The current literature on body composition in PKU is still inconclu-
sive. However, accurate measurements of peripheral markers in PKU
patients are important to evaluate nutritional status which, in turn,
can improve individual dietary management. Therefore, this study
aimed to characterize body composition parameters and nutritional
status in Brazilian PKU patients.
2. Methods
2.1. Participants
A cross-sectional study with PKU patients and age- and gender-
matched healthy controls was conducted. Patients were recruited at
the Medical Genetics Service from the Hospital de Clínicas de Porto
Alegre (HCPA), Brazil. Controls were recruited in a routine follow-up
at the Pediatric Service from the same hospital. Inclusion criteria includ-
ed being aged 5 years or older and being able to lie quietly during the
BIA test.
The study has been approved by the Research Ethics Committee
of HCPA (protocol number 12-0115) and was conducted according
to the Declaration of Helsinki guidelines. All subjects or their parents/
caregivers signed an informed consent form.
2.2. Patients' characterization
PKU typewas deﬁned asmild- or classical PKU according to patients'
Phe levels at diagnosis if levels were between 600–1200 μmol/L and
N1200 μmol/L, respectively. Time of diagnosis was deﬁned as early
when patients were diagnosed before 60 days of life, and late when
diagnosed at 60 days or older. Metabolic control was assessed by the
median of historical serum Phe concentrations measured in the previ-
ous 12months, with a minimum of three measurements in that period.
Thus, patients were classiﬁed as having good metabolic control if those
Phe levelswere ≤360 μmol/L and ≤600 μmol/L for patients aged ≤12 and
N12 years, respectively; otherwise, patients were classiﬁed as having
poor metabolic control. All patients were following treatment since di-
agnosis, and it consisted of having a low-Phe diet and the L-amino acidmixture. No patient was on tetrahydrobiopterin (BH4) treatment before
or during the study.
2.3. Anthropometric measurements
Height was measured with a wall-mounted stadiometer
(Harpenden, Holtain®, Crymych, UK) to the nearest 0.1 cm and weight
was obtained using a digital platform scale with a resolution of 0.1 kg
(Toledo®, Model 2096PP/2, São Paulo, Brazil), while participants were
barefoot and wearing lightweight clothing. BMI was calculated by the
quotient between weight (kg) and squared height (m2), and classiﬁed
into underweight, normal weight, overweight, or obese according to
WHO 2009 [25].
2.4. BIA analysis
Measurements of body composition such as FM, FFM, ECM/BCM
ratio, and PA were performed using a BIA device (Biodynamics 450®
version 5.1, Biodynamics Corporation, Seattle, WA, USA) and Resting
ECG tab electrodes (Conmed Corporation, Utica, NY, USA) according to
previously described standards [26]. Brieﬂy, the participants laid in su-
pine position with arms and legs stretched out and kept from touching
the body by non-conductor foam objects to prevent from adduction or
crossing of the limbs, which would shorten the electrical circuit and
reduce the impedance values. One pair of electrodes was placed on
the right wrist and hand and the other on the right ankle and foot of
the participant.
2.5. Statistical analysis
The Statistical Package for Social Sciences 19.0 (SPSS® Inc., Chicago,
IL) was used. Data were described using absolute and relative frequen-
cies. Continuous variables were expressed as mean ± standard devia-
tion (SD). Unpaired and paired Student's t-tests were used to compare
means of independent variables and to compare means between
patients and controls, respectively. Effects of the co-factors were tested
by ANOVA. The level of signiﬁcance was set at 5%.
Table 2
Anthropometrics and bioelectrical impedance parameters of phenylketonuria (PKU) pa-
tients and controls.
PKU Controls p value
Weight (kg) 47.93 ± 15.99 51.52 ± 18.15 NS
Height (m) 1.52 ± 0.14 1.54 ± 0.17 NS
BMI (kg/m2) 20 ± 4 21 ± 4 NS
BMI classiﬁcationa (n) NS
Underweight 1 (4%) 0 (0%)
Normal weight 20 (74%) 18 (67%)
Overweight 4 (15%) 6 (22%)
Obese 2 (7%) 3 (11%)
Fat mass (%) 20 ± 7 22 ± 9 NS
Free-fat mass (%) 80 ± 7 78 ± 9 NS
ECM/BCM ratio 1.05 ± 0.08 1.04 ± 0.10 NS
Phase angle (°) 6.22 ± 0.86 6.33 ± 1.05 NS
BMI, body mass index; ECM/BCM, extracellular mass/body cell mass; NS, non-signiﬁcant.
Fat mass and fat-free mass are expressed as percentage of total body weight. Data are
expressed as mean ± SD or frequency (percentage); n = 27/group.
a According to WHO 2009. See the text for details on statistics.
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Each group of patients and controls had 27 participants (14 males
and 13 females); patients originated from 26 nonrelated families.
Concerning PKU type, 14 (52%) patients were mild PKU and 13 (48%)
were classical PKU (Table 1). Eleven (41%) patients were early diag-
nosed and 16 (59%) patients were late diagnosed. Current Phe levels
ranged between 102 and 1660 μmol/Lwhile historical Phe levels ranged
between 258 and 1482 μmol/L. Regarding treatment adherence, 13
(48%) patients had good metabolic control and 14 (51%) patients had
poor metabolic control. The cofactors type of PKU, time of diagnosis,
and metabolic control did not affect the anthropometric and BIA-
derived measurements; thereby all patients were grouped in a single
PKU group for further analyses.
No differences were found between PKU patients and controls re-
garding body composition, including the BIA-derived parameters FM,
FFM, ECM/BCM ratio, and PA (Table 2). Three patients and threeTable 3
Review of literature on studies regarding body composition in early treated phenylketonuria (
Authors/location Controlled Number (n)/age Type of PKU






Doulgeraki et al. (2014)
Greece [28]
Yes 80
10 ± 3 (range
5–18)
Mild, classical







Douglas et al. (2013)
USA [34]
Noa 59 (range 10–19) Classical




























ECM/BCM, extracellular mass/body cell mass ratio; HPA, hyperphenylalaninemia; DXA, dual en
mography; TOBEC, total body electrical conductivity; N/E, not evaluated. Values of age are sho
a Non-controlled study that compared the results from patients with reference values.controls were below the cutoff values for PA (−3.2%, −14.3%,
−17.4%, and−2.4%,−2.8%, −4.4%, respectively) according to Bosy-
Westphal et al. [27] and Barbosa-Silva and Barros [18].
4. Discussion
This is the ﬁrst study evaluating the body composition of Brazilian
PKU patients, which represent a heterogeneous cohort of patients that
differs from those from Europe and USA in terms of diagnosis, treat-
ment, and ethnicity. First, the proportion of late-diagnosed patients in
Brazil is still high, since the mandatory Neonatal Screening Program
was implemented in 2001 in Brazil. Moreover, Brazilian PKU patients,
although having access to the L-amino acid mixture, do not have access
to protein-enriched low-Phe food, a fact that could compromise their
nutritional status. Finally, Brazil is essentially a mixed country with sev-
eral ethnic backgrounds. In this way, patients with different PKU types,
time of diagnosis, and treatment adherence were included in our study,
therefore these factors were also taken into account in the analysis of
our results. Even though BIA analysis gives more accurate values on
body composition than overall measurements such as BMI [16], our
study did not ﬁnd differences between patients and controls regarding
anthropometric features evaluated by both methods. Therefore, our
main ﬁndings pointed out that patients and controls were similar in
body composition parameters, despite PKU type, time of diagnosis,
and metabolic control. To the best of our knowledge, this is the ﬁrst
study that evaluated several markers on body composition in a hetero-
geneous group of PKU patients using BIA analysis.
Overweight has been pointed out as an issue for PKU patients, al-
though this is not a consensus in the literature (Table 3). This disagree-
ment in the literaturemay be caused by a lack of control for the puberty
status of patients, since most studies, including ours, evaluate pre- and
post-pubertal patients in a single group. In this way, some studies
have found that PKU patients, especially females, show higher BMI
and fat mass than controls [11,12]. On the other hand, several authors
have not found differences in body composition between patients and
age-matched controls [14,15,28–30] as well as comparing patients' out-






BIA Normal Normal Normal Normal
DXA No difference No
difference
N/E N/E




ADP Normal N/E N/E N/E




TOBEC No difference No
difference
N/E N/E
BIA Normal Normal N/E N/E
Skinfold-thickness No difference No
difference
N/E N/E
ergy X-ray absorptiometry; BIA, bioelectrical impedance; ADP, air displacement plethys-
wn as mean ± SD if not stated otherwise.
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over, no differences in body composition were found between patients
and controls. Although not at higher risk of developing obesity, PKU
patients may show the same risk of having disturbed body composition
as the general population. Then, it is important to highlight that Brazil is
undergoing an epidemiological transition associated with demographic
and nutritional changes, which has led to high prevalence of obesity
especially for the age group and geographic area covered by our study
[35,36].
BIA analysis provides a range of data that assesses overall nutritional
status such as relative active tissue (ECM/BCM ratio) and cellular integ-
rity (PA), which can be of interest to PKUpatients. In our study, values of
ECM/BCM ratio and PA were similar between patients and controls. In
agreement with our results, Rocha et al. [15] have found similar PA
and body cell mass index values between Portuguese PKU patients
and controls. In other pathologic conditions, ECM/BCM ratio has posi-
tively correlated with risk of death in dialysis patients [19], while PA
has been negatively affected by nutritional imbalances, thus used as a
prognostic factor in patients with homocystinuria [20] and cancer
[21]. Both ECM/BCM ratio and PA values have been related to increased
inﬂammation [17–19,21], which are seen in several pathological pro-
cesses including in PKUpatients [37,38]. Because nutritional imbalances
have shown to underlie increased inﬂammation [23,24], the Phe-
restricted diet could represent a threat to the overall health of patients.
In addition, Brazilian PKU patients do not have adequate insurance
coverage for commercial low-Phe products [2,5,6], which compromises
the adherence to the dietary treatment. Despite that, the PKUpatients of
our study were not in higher risk of nutritional disturbances than the
general population.
5. Conclusions
Overall, our results pointed to similar values of body composition
and nutritional parameters between PKU patients and controls. More-
over, the analyzed values were not affected by the PKU type, time of
diagnosis, or metabolic control.
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